Brainsway Ltd (BWAY) - Net Assets

Latest as of September 2025: ILA70.06 Million ILA ≈ $187.84K USD

Based on the latest financial reports, Brainsway Ltd (BWAY) has net assets worth ILA70.06 Million ILA (≈ $187.84K USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA113.06 Million ≈ $303.12K USD) and total liabilities (ILA43.00 Million ≈ $115.27K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Brainsway Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	ILA70.06 Million
% of Total Assets	61.97%
Annual Growth Rate	17.49%
5-Year Change	217.37%
10-Year Change	383.23%
Growth Volatility	87.64

Brainsway Ltd - Net Assets Trend (2012–2024)

This chart illustrates how Brainsway Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Brainsway Ltd asset portfolio for the complete picture of this company's asset base.

Annual Net Assets for Brainsway Ltd (2012–2024)

The table below shows the annual net assets of Brainsway Ltd from 2012 to 2024. For live valuation and market cap data, see market value of Brainsway Ltd.

Year	Net Assets	Change
2024-12-31	ILA62.31 Million ≈ $167.06K	+49.86%
2023-12-31	ILA41.58 Million ≈ $111.48K	-8.41%
2022-12-31	ILA45.40 Million ≈ $121.71K	-20.81%
2021-12-31	ILA57.32 Million ≈ $153.68K	+191.96%
2020-12-31	ILA19.63 Million ≈ $52.64K	-18.93%
2019-12-31	ILA24.22 Million ≈ $64.93K	+248.39%
2018-12-31	ILA6.95 Million ≈ $18.64K	-45.35%
2017-12-31	ILA12.72 Million ≈ $34.10K	+23.66%
2016-12-31	ILA10.29 Million ≈ $27.58K	-20.22%
2015-12-31	ILA12.89 Million ≈ $34.57K	-17.22%
2014-12-31	ILA15.58 Million ≈ $41.76K	+6.32%
2013-12-31	ILA14.65 Million ≈ $39.28K	+62.65%
2012-12-31	ILA9.01 Million ≈ $24.15K	--

Equity Component Analysis

This analysis shows how different components contribute to Brainsway Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 6983505400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	ILA413.00K	0.66%
Other Comprehensive Income	ILA-2.19 Million	-3.51%
Other Components	ILA162.47 Million	260.73%
Total Equity	ILA62.31 Million	100.00%

Brainsway Ltd Competitors by Market Cap

The table below lists competitors of Brainsway Ltd ranked by their market capitalization.

Company	Market Cap
Bridgewater Bancshares Inc NASDAQ:BWB	$510.30 Million
Empresa Distribuidora y Comercializadora Norte Sociedad Anónima F:PWD1	$510.32 Million
Organización Cultiba S.A.B. de C.V MX:CULTIBAB	$510.32 Million
Zenitron Corp TW:3028	$510.50 Million
Beijing Waluer Information Technology Co. Ltd. A SHE:301380	$510.09 Million
CoinShares International Ltd ST:CS	$509.93 Million
Donegal Group A Inc NASDAQ:DGICA	$509.77 Million
Samhällsbyggnadsbolaget i Norden AB (publ) ST:SBB-B	$509.55 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Brainsway Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 41,581,000 to 62,313,000, a change of 20,732,000 (49.9%).
Net income of 2,921,000 contributed positively to equity growth.
New share issuances of 16,353,000 increased equity.
Other factors increased equity by 1,458,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	ILA2.92 Million	+4.69%
Share Issuances	ILA16.35 Million	+26.24%
Other Changes	ILA1.46 Million	+2.34%
Total Change	ILA-	49.86%

Book Value vs Market Value Analysis

This analysis compares Brainsway Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2707.28x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 12064.06x to 2707.28x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-12-31	ILA0.40	ILA4852.00	x
2013-12-31	ILA0.61	ILA4852.00	x
2014-12-31	ILA1.09	ILA4852.00	x
2015-12-31	ILA0.89	ILA4852.00	x
2016-12-31	ILA0.71	ILA4852.00	x
2017-12-31	ILA0.86	ILA4852.00	x
2018-12-31	ILA0.42	ILA4852.00	x
2019-12-31	ILA1.18	ILA4852.00	x
2020-12-31	ILA0.88	ILA4852.00	x
2021-12-31	ILA1.84	ILA4852.00	x
2022-12-31	ILA1.48	ILA4852.00	x
2023-12-31	ILA1.25	ILA4852.00	x
2024-12-31	ILA1.79	ILA4852.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Brainsway Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 4.69%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 7.12%
• Asset Turnover: 0.43x
• Equity Multiplier: 1.51x
Recent ROE (4.69%) is above the historical average (-44.13%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2012	-120.88%	-1624.27%	0.03x	2.18x	ILA-6.41 Million
2013	-91.00%	-598.99%	0.07x	2.28x	ILA-7.90 Million
2014	-42.02%	-193.64%	0.13x	1.65x	ILA-8.10 Million
2015	-31.69%	-60.10%	0.31x	1.72x	ILA-5.38 Million
2016	-23.30%	-20.80%	0.58x	1.94x	ILA-3.43 Million
2017	-55.45%	-63.29%	0.41x	2.12x	ILA-8.33 Million
2018	-93.20%	-39.51%	0.69x	3.39x	ILA-7.17 Million
2019	-42.64%	-44.71%	0.60x	1.60x	ILA-12.75 Million
2020	-27.43%	-24.41%	0.65x	1.73x	ILA-7.35 Million
2021	-11.27%	-21.79%	0.39x	1.32x	ILA-12.19 Million
2022	-29.41%	-49.12%	0.42x	1.42x	ILA-17.89 Million
2023	-10.09%	-13.20%	0.50x	1.51x	ILA-8.36 Million
2024	4.69%	7.12%	0.43x	1.51x	ILA-3.31 Million

Industry Comparison

This section compares Brainsway Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $120,607,444
Average return on equity (ROE) among peers: -19.28%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Brainsway Ltd (BWAY)	ILA70.06 Million	-120.88%	0.61x	$510.18 Million
Allmed Solutions Ltd (ALMD)	$42.02 Million	-20.83%	0.07x	$9.25 Million
Erika Carmel Ltd (BCUR)	$88.06 Million	-24.76%	0.42x	$4.69 Million
Bio-View Ltd (BIOV)	$1.55 Million	72.16%	8.48x	$5.69 Million
Erech Finance Cahalacha Ltd (EFNC)	$30.07 Million	4.47%	1.44x	$1.93 Million
Epitomee Medical Ltd (EPIT)	$3.98 Million	-79.63%	4.36x	$68.42 Million
Erika Carmel-Tech Ltd (ERKA)	$15.04 Million	-62.98%	1.31x	$12.59 Million
Human Xtensions Ltd (HUMX)	$104.53 Million	-51.30%	0.15x	$2.12 Million
Ilex Medical (ILX)	$646.49 Million	6.03%	0.54x	$165.24 Million
Pulsenmore Ltd (PULS)	$153.73 Million	-16.67%	0.09x	$22.89 Million

About Brainsway Ltd

TA:BWAY Israel Medical Devices

Market Cap

$510.18 Million

ILA190.30 Billion ILA

Market Cap Rank

#12437 Global

#135 in Israel

Share Price

ILA4852.00

Change (1 day)

+2.23%

52-Week Range

ILA1553.00 - ILA4965.00

All Time High

ILA4965.00